title: Exploring and exploiting the aberrant DNA methylation profile of endocrine-resistant breast cancer.
authors.affiliation: Cancer Epigenetics Program, Garvan Institute of Medical Research, Sydney, NSW, Australia. a.stone@garvan.org.au.
authors.forename: Andrew
authors.initials: A
authors.lastname: Stone
authors.forename: Fatima
authors.initials: F
authors.lastname: Valdes-Mora
authors.forename: Susan J
authors.initials: SJ
authors.lastname: Clark
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D014408:Biomarkers, Tumor; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D019175:DNA Methylation; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D019254:Genes, bcl-2; D006801:Humans; D057089:Pathology, Molecular
chemical_list: D018931:Antineoplastic Agents, Hormonal; D014408:Biomarkers, Tumor